Bruker (BRKR) Net Equity Issued and Repurchased (2010 - 2025)

Bruker (BRKR) has 16 years of Net Equity Issued and Repurchased data on file, last reported at $665.6 million in Q4 2025.

• Quarterly Net Equity Issued and Repurchased rose 20700.0% year-over-year to $665.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $669.7 million (up 63.74% YoY) and the FY2025 annual result came in at $669.7 million, up 63.74% from the prior year.
• Net Equity Issued and Repurchased improved to $665.6 million in Q4 2025, from -$1.2 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $665.6 million in Q4 2025 to a low of -$2.8 million in Q3 2024.
• A 5-year average of $54.9 million and a median of $2.0 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased sank 240.0% — and 2025, when it surged 20700.0%.
• Tracing BRKR's Net Equity Issued and Repurchased over 5 years: stood at $1.1 million in 2021, then jumped by 81.82% to $2.0 million in 2022, then soared by 135.0% to $4.7 million in 2023, then slumped by 31.91% to $3.2 million in 2024, then surged by 20700.0% to $665.6 million in 2025.
• The last three Net Equity Issued and Repurchased figures came in at $665.6 million (Q4 2025), -$1.2 million (Q3 2025), and $4.9 million (Q2 2025), per Business Quant data.